Search filters

List of works by George Dranitsaris

A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy

scientific article published on 02 May 2007

A clinical and economic evaluation of red blood cell transfusions in patients receiving cancer chemotherapy

scientific article published on 01 January 1998

A comparison of toxicity and health care resource use between eribulin, capecitabine, gemcitabine, and vinorelbine in patients with metastatic breast cancer treated in a community oncology setting

scientific article published on 11 March 2014

A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach.

scientific article

A country level analysis measuring the impact of government actions, country preparedness and socioeconomic factors on COVID-19 mortality and related health outcomes

scientific article published on 21 July 2020

A multinational study to measure the value that patients with cancer place on improved emesis control following cisplatin chemotherapy.

scientific article

A pharmacoeconomic modeling approach to estimate a value-based price for new oncology drugs in Europe.

scientific article published on 7 March 2011

A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases

scientific article published in January 2010

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.

scientific article published on 18 March 2014

A pilot study to evaluate the feasibility of using willingness to pay as a measure of value in cancer supportive care: an assessment of amifostine cytoprotection ⬇️

scientific article published on November 1, 1997

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer

scientific article published in January 2010

A randomized trial of the effects of pharmacist intervention on the cost of antiemetic therapy with ondansetron ⬇️

scientific article published on May 1, 1995

A randomized trial to measure the optimal role of the pharmacist in promoting evidence-based antibiotic use in acute care hospitals

scientific article

A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer

scientific article published on 7 December 2015

A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally adva

A structured group exercise program for patients with metastatic cancer receiving chemotherapy and CTNNB1 (β-catenin) as a biomarker of exercise efficacy

scientific article published on 13 October 2017

A vancomycin drug use evaluation and economic analysis in a cancer treatment centre

scientific article

Abraxane Versus Taxol For Patients with Advanced Breast Cancer: A Prospective Time and Motion Analysis from a Chinese Health Care Perspective

scientific article published on 26 October 2014

Abraxane® versus Taxol® for patients with advanced breast cancer: A prospective time and motion analysis from a Chinese health care perspective

scientific article

Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia

scientific article

Advances in cancer therapeutics and patient access to new drugs.

scientific article published on March 2011

Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer.

scientific article published in July 2009

Are Estring® and Vagifem® equally effective and safe for the treatment of urogenital atrophy in breast cancer patients on aromatase inhibitor therapy?

scientific article published on 12 July 2012

Are community pharmacists equipped to ensure the safe use of oral anticancer therapy in the community setting? Results of a cross-country survey of community pharmacists in Canada

scientific article published on 8 October 2013

Are health care providers who work with cancer drugs at an increased risk for toxic events? A systematic review and meta-analysis of the literature

scientific article

Author reply

Bcl2-interacting killer CpG methylation in multiple myeloma: a potential predictor of relapsed/refractory disease with therapeutic implications

scientific article published on 13 March 2012

Bevacizumab in Combination with folfiri Chemotherapy in Patients with Metastatic Colorectal Cancer: An Assessment of Safety and Efficacy in the Province of Newfoundland and Labrador ⬇️

scientific article published on October 1, 2010

Bioavailability of iron in oral ferrous sulfate preparations in healthy volunteers

scientific article published on September 1989

Biosimilars of biological drug therapies: regulatory, clinical and commercial considerations.

scientific article

Bisphosphonate use for the management of breast cancer patients with bone metastases: a survey of Canadian Medical Oncologists

scientific article published on 21 August 2004

Chemotherapy-induced anaemia during adjuvant treatment for breast cancer: development of a prediction model

scientific article published in November 2005

Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study

scientific article published in September 2007

Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting

scientific article published on 5 January 2016

Clinical Outcomes of Women with Metastatic Breast Cancer Treated with Nab-Paclitaxel: Experience from a Single Academic Cancer Centre ⬇️

scientific article published on February 1, 2013

Clinical and economic analysis of allogeneic peripheral blood progenitor cell transplants: a Canadian perspective

scientific article published on 01 December 1998

Clinical and economic considerations of empirical antibacterial therapy of febrile neutropenia in cancer

scientific article

Clinical trial design in biosimilar drug development.

scientific article

Clinico-morphological features of BRAF inhibition-induced proliferative skin lesions in cancer patients.

scientific article published on 3 September 2014

Cohort versus patient level simulation for the economic evaluation of single versus combination immuno-oncology therapies in metastatic melanoma

scientific article published on 30 January 2019

Comparative effectiveness analysis of monotherapy with cytotoxic agents in triple-negative metastatic breast cancer in a community setting

scientific article published on 26 November 2014

Comparing the Results of Bisphosphonate Use in Clinical Trials with Actual Practice: A Case of Apples and Oranges? ⬇️

scientific article published on October 1, 2006

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death

scientific article published in March 2005

Correlation between progression-free survival and overall survival in metastatic breast cancer patients receiving anthracyclines, taxanes, or targeted therapies: a trial-level meta-analysis.

scientific article

Cost effective evaluation of a stability study

scientific article published on 01 August 1987

Cost effectiveness vs. affordability in the age of immuno-oncology cancer drugs

scientific article published on 25 April 2018

Cost utility analysis of first-line hormonal therapy in advanced breast cancer: comparison of two aromatase inhibitors to tamoxifen

scientific article

Cost utility analysis of prophylactic pamidronate for the prevention of skeletal related events in patients with advanced breast cancer

scientific article published on 01 July 1999

Cost-Effectiveness Modelling of Sofosbuvir-Containing Regimens for Chronic Genotype 5 Hepatitis C Virus Infection in South Africa.

scientific article

Cost-benefit analysis of prophylactic granulocyte colony-stimulating factor during CHOP antineoplastic therapy for non-Hodgkin's lymphoma

scientific article published on June 1997

Cost-effectiveness of chemotherapy for nonsmall-cell lung cancer

scientific article

Cost-utility analysis of chemotherapy using paclitaxel, docetaxel, or vinorelbine for patients with anthracycline-resistant breast cancer

scientific article

Cost-utility analysis of paclitaxel in combination with cisplatin for patients with advanced ovarian cancer.

scientific article

Cost-utility analysis of second-line hormonal therapy in advanced breast cancer: a comparison of two aromatase inhibitors to megestrol acetate

scientific article published in August 2000

CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes

scientific article published in February 2010

Dalteparin or vitamin K antagonists to prevent recurrent venous thromboembolism in cancer patients: a patient-level economic analysis for France and Austria

scientific article published on 15 February 2017

Dalteparin versus vitamin K antagonists for the prevention of recurrent venous thromboembolism in patients with cancer and renal impairment: a Canadian pharmacoeconomic analysis

scientific article published on 10 January 2017

Dalteparin versus warfarin for the prevention of recurrent venous thromboembolic events in cancer patients: a pharmacoeconomic analysis

scientific article published on 01 January 2006

Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients' experience.

scientific article published on 25 June 2015

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients.

scientific article published on 23 June 2009

Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib ⬇️

scientific article published on January 6, 2012

Development of prediction tools for diarrhea and rash in breast cancer patients receiving lapatinib in combination with capecitabine.

scientific article

Do physicians follow systemic treatment and funding policy guidelines?

scientific article published in March 2004

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

scientific article published on 18 March 2009

Does prolonging the time to bladder cancer surgery affect long-term cancer control: a systematic review of the literature

scientific article published on June 2006

Does prolonging the time to prostate cancer surgery impact long-term cancer control: a systematic review of the literature

scientific article published on June 2006

Does prolonging the time to renal cancer surgery affect long-term cancer control: a systematic review of the literature.

scientific article published on June 2006

Does prolonging the time to testicular cancer surgery impact long-term cancer control: a systematic review of the literature

scientific article published on June 2006

Drug tendering: drug supply and shortage implications for the uptake of biosimilars

scientific article published on 29 September 2017

Economic Analysis Comparing Dalteparin to Vitamin K Antagonists to Prevent Recurrent Venous Thromboembolism in Patients With Cancer Having Renal Impairment

scientific article published on 19 July 2016

Economic Evaluation of Single versus Combination Immuno-Oncology Therapies: Application of a Novel Modelling Approach in Metastatic Melanoma

scientific article published on 06 May 2020

Economic analyses of toxicity secondary to anthracycline-based breast cancer chemotherapy

scientific article published on December 1995

Economic analysis of albumin-bound paclitaxel for the treatment of metastatic breast cancer

scientific article published on 26 November 2008

Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients

scientific article published on 01 May 1998

Economic analysis of prophylactic G-CSF after mini-BEAM salvage chemotherapy for Hodgkin's and non-Hodgkin's lymphoma

scientific article published on March 1995

Economic evaluation in collaborative hospital drug evaluation reports.

scientific article published on September 2015

Estimating the cost of illness in colorectal cancer patients who were hospitalized for severe chemotherapy-induced diarrhea

scientific article

Evaluating the impact of bevacizumab maintenance therapy on overall survival in advanced non-small-cell lung cancer

scientific article published on 04 August 2012

Extended dalteparin prophylaxis for venous thromboembolic events: cost-utility analysis in patients undergoing major orthopedic surgery

scientific article published in January 2009

External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer

scientific article

FOLFOX chemotherapy can safely be given to neutropenic patients with early-stage colorectal cancer for higher dose intensity and fewer visits

scientific article published on 22 December 2015

Full-dose chemotherapy in early stage breast cancer regardless of absolute neutrophil count and without G-CSF does not increase chemotherapy-induced febrile neutropenia ⬇️

scientific article published on May 26, 2013

Health technology assessment of cancer drugs in Canada, the United Kingdom and Australia: should the United States take notice?

scientific article published on June 2015

Identifying patients at high risk for neutropenic complications during chemotherapy for metastatic breast cancer with doxorubicin or pegylated liposomal doxorubicin: the development of a prediction model

scientific article published in August 2008

Impact of aprepitant on emesis control, dose intensity, and recurrence-free survival in a population-based cohort of head and neck cancer patients receiving high-dose cisplatin chemotherapy

scientific article published on 01 November 2014

Implementing evidence based antiemetic guidelines in the oncology setting: results of a 4-month prospective intervention study ⬇️

scientific article published on November 1, 2001

Improving patient access to cancer drugs in India: Using economic modeling to estimate a more affordable drug cost based on measures of societal value

scientific article published on 01 January 2011

Improving the Cost Efficiency of PD-1/PD-L1 Inhibitors for Advanced Urothelial Carcinoma: A Major Role for Precision Medicine?

scientific article published on 10 April 2018

Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey

scientific article

Interpreting results from oncology clinical trials: a comparison of denosumab to zoledronic acid for the prevention of skeletal-related events in cancer patients.

scientific article

JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality

scientific article published on 13 November 2020

Lanreotide vs octreotide LAR for patients with advanced gastroenteropancreatic neuroendocrine tumors: An observational time and motion analysis

scientific article published on 29 March 2019

Low-molecular-weight heparins for the prevention of recurrent venous thromboembolism in patients with cancer: A systematic literature review of efficacy and cost-effectiveness.

scientific article published on January 2017

Management of patients with Cushing's disease: a Canadian cost of illness analysis

scientific article published on 28 November 2014

Measuring the impact of guideline-based antiemetic therapy on nausea and vomiting control in breast cancer patients with multiple risk factors

scientific article published on 17 September 2015

Measuring treatment preferences and willingness to pay for docetaxel in advanced ovarian cancer

scientific article published in January 2004

Meta regression analysis to indirectly compare dalteparin to enoxaparin for the prevention of venous thromboembolic events following total hip replacement

scientific article

Meta-analyses of placebo-controlled trials of acamprosate for the treatment of alcohol dependence: impact of the combined pharmacotherapies and behavior interventions study

scientific article published on June 2009

Meta-regression analysis to indirectly compare prophylaxis with dalteparin or enoxaparin in patients at high risk for venous thromboembolic events

scientific article

Modeling the economic outcomes of immuno-oncology drugs: alternative model frameworks to capture clinical outcomes.

scientific article published on 8 March 2018

Modelling the Survival Outcomes of Immuno-Oncology Drugs in Economic Evaluations: A Systematic Approach to Data Analysis and Extrapolation

scientific article published on 2 September 2017

Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc): A Cost Utility Analysis from a Chinese Health Care Perspective

scientific article published on 26 October 2014

Nab-paclitaxel, docetaxel, or solvent-based paclitaxel in metastatic breast cancer: a cost-utility analysis from a Chinese health care perspective

scientific article published on 12 May 2015

Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists

scientific article published on 22 July 2011

Oral therapies for the treatment of pulmonary arterial hypertension: a population-based cost-minimization analysis.

scientific article published in January 2009

Outcomes assessment of a pharmacist-directed seamless care program in an ambulatory oncology clinic.

scientific article

Pamidronate for the prevention of skeletal-related events in multiple myeloma. What does the public think it is worth?

scientific article published on 01 January 1999

Patient monitoring programs in oncology pharmacy practice: A survey of oncology pharmacists in Atlantic Canada

article

Pharmacoeconomic analysis of empirical therapy with ceftazidime alone or combination antibiotics for febrile neutropenia in cancer patients

scientific article published on January 1995

Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patients

scientific article published in January 2004

Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy

scientific article published on 25 September 2006

Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions.

scientific article published on 22 February 2011

Posaconazole versus fluconazole or itraconazole for prevention of invasive fungal infections in patients undergoing intensive cytotoxic therapy for acute myeloid leukemia or myelodysplasia: a cost effectiveness analysis ⬇️

scientific article published on October 23, 2010

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients.

scientific article published on 24 June 2009

Preference weights for chemotherapy side effects from the perspective of women with breast cancer.

scientific article

Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer

scientific article

Prevention and management of chemotherapy-induced diarrhea in patients with colorectal cancer: a consensus statement by the Canadian Working Group on Chemotherapy-Induced Diarrhea

scientific article published in February 2007

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

scientific article

Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting

scientific article published in March 2013

Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting.

scientific article

Randomized feasibility study of de-escalated (every 12 wk) versus standard (every 3 to 4 wk) intravenous pamidronate in women with low-risk bone metastases from breast cancer

scientific article

Recent developments in bisphosphonates for patients with metastatic breast cancer

scientific article

Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial

scientific article

Risk prediction models for chemotherapy-induced nausea and vomiting: almost ready for prime time?

scientific article published on 29 January 2014

Severe chemotherapy-induced diarrhea in patients with colorectal cancer: a cost of illness analysis

scientific article published on 22 December 2004

Severe diarrhea in patients with advanced-stage colorectal cancer receiving FOLFOX or FOLFIRI chemotherapy: the development of a risk prediction tool

scientific article published on 01 January 2007

Small molecule targeted therapies for the second-line treatment for metastatic renal cell carcinoma: a systematic review and indirect comparison of safety and efficacy

scientific article

Statistical Considerations in Clinical Trial Design of Immunotherapeutic Cancer Agents

scientific article published on September 2015

Sterile versus nonsterile gloves for repair of uncomplicated lacerations in the emergency department: a randomized controlled trial

scientific article published in March 2004

Study of specific genetic and epigenetic variables in multiple myeloma.

scientific article published on 11 November 2010

Sublingual or Subcutaneous immunotherapy for Seasonal Allergic Rhinitis (AR): an indirect analysis of efficacy, safety and cost

scientific article published on 3 March 2014

Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost

scientific article published on 21 January 2014

Surgical wait times for patients with urological cancers: a survey of Canadian surgeons

scientific article published on 01 June 2006

Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane.

scientific article published on June 2007

Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design

scientific article published on February 2009

Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain

scientific article

Systemic treatment of bone metastases from breast cancer: is it all that it's cracked up to be?

scientific article published on 01 July 2005

The application of pharmacoeconomic modelling to estimate a value-based price for new cancer drugs.

scientific article

The autologous blood and marrow transplant long-term follow-up clinic: a model of care for following and treating survivors of autotransplant

scientific article

The development and validation of a prediction tool for chemotherapy-induced anemia in patients with advanced nonsmall cell lung cancer receiving palliative chemotherapy

scientific article published on 21 November 2006

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

scientific article

The development of a predictive model to estimate cardiotoxic risk for patients with metastatic breast cancer receiving anthracyclines

scientific article published on 3 November 2007

The development of a value based pricing index for new drugs in metastatic colorectal cancer.

scientific article

The economic value of a new insulin preparation, Humalog Mix 25. Measured by a willingness-to-pay approach

scientific article published on 01 September 2000

The impact of practice guidelines and funding policies on the use of new drugs in advanced non-small cell lung cancer

scientific article published in August 2005

The price function of toxicity

article

The prolyl-hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia.

scientific article

The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study

scientific article

Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer

scientific article

Treatment of non-Hodgkin's lymphoma

scientific article published on 01 November 1998

Urinary N-telopeptide is a rapid predictor of response to and palliative benefit from bisphosphonate therapy in patients with metastatic breast cancer

scientific article published on September 2007

Use and Delivery of Granulocyte Colony–Stimulating Factor in Breast Cancer Patients Receiving Neoadjuvant or Adjuvant Chemotherapy—Single-Centre Experience ⬇️

scientific article published on August 1, 2012

Using decision modeling to determine pricing of new pharmaceuticals: the case of neurokinin-1 receptor antagonist antiemetics for cancer chemotherapy

scientific article published in January 2004

Using filgrastim efficiently

scientific article published on 01 May 1996

Using pharmacoeconomic modelling to determine value-based pricing for new pharmaceuticals in malaysia ⬇️

scientific article published on October 1, 2011

Vascular endothelial growth factor activity after switching of bisphosphonate treatment for metastatic breast cancer.

scientific article published in May 2009

Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease.

scientific article

What are cancer patients willing to pay for prophylactic epoetin alfa? A cost-benefit analysis

scientific article published on 01 December 1998

What is a new drug worth? An innovative model for performance-based pricing

scientific article published on 25 September 2014

What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer?

scientific article published in September 2005

nab-Paclitaxel weekly or every 3 weeks compared to standard docetaxel as first-line therapy in patients with metastatic breast cancer: an economic analysis of a prospective randomized trial

scientific article published on 3 June 2009

Paulina is supported by:

About Paulina

Help